A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

NCT02326194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

Ebola Virus Disease

Interventions

BIOLOGICAL: Low dose Ebola Zaire vaccine (Ad5-EBOV)
BIOLOGICAL: High dose Ebola Zaire vaccine (Ad5-EBOV)
BIOLOGICAL: placebo (one dose)
BIOLOGICAL: placebo (two doses)

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]